A carregar...
The dawn of mRNA vaccines: The COVID-19 case
In less than one year since the outbreak of the COVID-19 pandemic, two mRNA-based vaccines, BNT162b2 and mRNA-1273, were granted the first historic authorization for emergency use, while another mRNA vaccine, CVnCoV, progressed to phase 3 clinical testing. The COVID-19 mRNA vaccines represent a new...
Na minha lista:
| Publicado no: | J Control Release |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier B.V.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8008785/ https://ncbi.nlm.nih.gov/pubmed/33798667 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2021.03.043 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|